Orum Therapeutics (475830)
오름테라퓨틱 KOSDAQ 기초 의약물질 제조업
Close (Aug 19, 2026)
₩70,300
+7.00%
Market cap
₩2T ($1.1B)
52-week range
₩22,650 –
₩146,600
P/E · P/B · Div yield
– · 11.40 ·
0%
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-08-19 | ₩70,300 | ₩-1.5bn | +₩6.2bn | ₩-4.8bn |
| 2026-08-18 | ₩65,700 | +₩2.9bn | ₩-1.4bn | ₩-1.5bn |
| 2026-08-14 | ₩68,100 | +₩1.0bn | ₩-0.4bn | ₩-0.5bn |
| 2026-08-13 | ₩66,900 | +₩0.1bn | ₩-0.1bn | +₩0.1bn |
| 2026-08-12 | ₩65,900 | +₩2.1bn | ₩-4.2bn | +₩2.4bn |
| 2026-08-11 | ₩71,000 | ₩-4.4bn | +₩3.9bn | +₩0.4bn |
| 2026-08-10 | ₩69,900 | ₩-4.1bn | +₩6.5bn | ₩-2.2bn |
| 2026-08-07 | ₩61,900 | ₩-1.2bn | +₩1.4bn | ₩-0.3bn |
| 2026-08-06 | ₩58,500 | ₩-1.9bn | +₩1.0bn | +₩0.9bn |
| 2026-08-05 | ₩59,000 | ₩-2.9bn | +₩1.4bn | +₩1.5bn |
| 2026-08-04 | ₩57,900 | ₩-6.1bn | +₩6.8bn | ₩-0.8bn |
| 2026-08-03 | ₩48,450 | ₩-0.1bn | +₩0.3bn | ₩-0.2bn |
| 2026-07-31 | ₩44,600 | +₩0.0bn | +₩0.3bn | ₩-0.3bn |
| 2026-07-30 | ₩37,800 | +₩0.2bn | +₩0.1bn | ₩-0.3bn |
| 2026-07-29 | ₩39,550 | ₩-0.2bn | +₩1.2bn | ₩-1.0bn |
| 2026-07-28 | ₩43,750 | ₩-0.3bn | +₩0.1bn | +₩0.2bn |
| 2026-07-27 | ₩47,450 | ₩-1.7bn | +₩1.3bn | +₩0.4bn |
| 2026-07-24 | ₩45,500 | +₩0.7bn | ₩-0.5bn | ₩-0.2bn |
| 2026-07-23 | ₩47,700 | ₩-0.7bn | +₩0.9bn | ₩-0.1bn |
| 2026-07-22 | ₩42,450 | +₩0.6bn | ₩-0.7bn | +₩0.1bn |
| 2026-07-21 | ₩41,900 | +₩0.4bn | +₩0.3bn | ₩-0.7bn |
| 2026-07-20 | ₩42,000 | +₩0.5bn | +₩0.0bn | ₩-0.5bn |
| 2026-07-16 | ₩45,400 | ₩-0.6bn | ₩-0.8bn | +₩1.3bn |
| 2026-07-15 | ₩48,400 | +₩0.4bn | +₩0.2bn | ₩-0.6bn |
| 2026-07-14 | ₩44,900 | +₩0.1bn | +₩0.4bn | ₩-0.4bn |
| 2026-07-13 | ₩45,400 | +₩0.4bn | ₩-0.6bn | +₩0.2bn |
| 2026-07-10 | ₩48,700 | +₩0.1bn | +₩1.3bn | ₩-1.3bn |
| 2026-07-09 | ₩46,300 | ₩-0.9bn | +₩1.0bn | ₩-0.1bn |
| 2026-07-08 | ₩47,550 | ₩-1.1bn | ₩-0.0bn | +₩1.2bn |
| 2026-07-07 | ₩50,800 | +₩0.6bn | +₩0.7bn | ₩-1.3bn |
| 2026-07-06 | ₩50,800 | ₩-0.3bn | ₩-0.1bn | +₩0.4bn |
| 2026-07-03 | ₩52,200 | ₩-1.4bn | +₩0.0bn | +₩1.4bn |
| 2026-07-02 | ₩53,100 | ₩-1.0bn | ₩-1.7bn | +₩2.6bn |
| 2026-07-01 | ₩57,800 | ₩-3.8bn | +₩0.8bn | +₩3.0bn |
| 2026-06-30 | ₩59,200 | ₩-2.1bn | +₩0.9bn | +₩1.8bn |
| 2026-06-29 | ₩62,200 | ₩-2.4bn | +₩5.6bn | ₩-4.0bn |
| 2026-06-26 | ₩49,300 | +₩2.2bn | +₩1.2bn | ₩-3.2bn |
| 2026-06-25 | ₩52,300 | ₩-0.3bn | ₩-0.8bn | +₩1.1bn |
| 2026-06-24 | ₩57,700 | +₩1.6bn | ₩-1.8bn | +₩0.2bn |
| 2026-06-23 | ₩56,400 | +₩3.0bn | +₩0.9bn | ₩-3.8bn |
| 2026-06-22 | ₩60,300 | ₩-0.5bn | +₩0.8bn | ₩-0.2bn |
| 2026-06-19 | ₩62,000 | +₩2.1bn | ₩-0.7bn | ₩-1.2bn |
| 2026-06-18 | ₩64,100 | ₩-0.4bn | +₩0.4bn | +₩0.2bn |
| 2026-06-17 | ₩70,000 | ₩-0.3bn | +₩2.4bn | ₩-2.2bn |
| 2026-06-16 | ₩63,700 | ₩-2.2bn | ₩-0.3bn | +₩2.7bn |
| 2026-06-15 | ₩63,200 | ₩-4.3bn | ₩-0.5bn | +₩4.9bn |
| 2026-06-12 | ₩67,900 | ₩-19.1bn | +₩18.9bn | +₩0.5bn |
| 2026-06-11 | ₩71,100 | ₩-44.3bn | +₩54.6bn | ₩-9.8bn |
| 2026-06-10 | ₩64,100 | +₩0.7bn | ₩-0.4bn | ₩-0.4bn |
| 2026-06-09 | ₩62,500 | +₩3.3bn | +₩0.1bn | ₩-3.1bn |
| 2026-06-08 | ₩54,900 | +₩9.3bn | ₩-2.1bn | ₩-7.3bn |
| 2026-06-05 | ₩63,100 | +₩2.4bn | ₩-0.3bn | ₩-2.1bn |
| 2026-06-04 | ₩64,100 | +₩2.2bn | ₩-0.2bn | ₩-2.0bn |
| 2026-06-02 | ₩63,700 | +₩4.3bn | +₩0.6bn | ₩-2.9bn |
| 2026-06-01 | ₩63,700 | +₩6.3bn | ₩-0.1bn | ₩-8.3bn |
| 2026-05-29 | ₩67,800 | +₩4.4bn | ₩-1.3bn | ₩-2.6bn |
| 2026-05-28 | ₩70,000 | +₩2.2bn | ₩-0.1bn | ₩-2.1bn |
| 2026-05-27 | ₩73,500 | ₩-1.5bn | +₩0.3bn | +₩1.4bn |
| 2026-05-26 | ₩73,500 | ₩-4.8bn | +₩0.7bn | +₩4.7bn |
| 2026-05-22 | ₩71,900 | +₩1.3bn | ₩-1.8bn | +₩0.0bn |
| 2026-05-21 | ₩65,500 | +₩0.9bn | ₩-1.5bn | +₩1.0bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | ₩-1.5bn | $-1M | +₩6.2bn | ₩-4.8bn |
| 5 days | +₩4.6bn | +$3M | +₩0.1bn | ₩-4.3bn |
| 20 days | ₩-17.7bn | $-13M | +₩24.0bn | ₩-6.3bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2024 | ₩21bn ($15M) | – | -₩8bn (-$6M) | -₩6bn (-$4M) |
| 2025 | ₩0bn ($0M) | -99.90% | -₩52bn (-$37M) | -₩42bn (-$30M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1410.07/$) for reference only.